IQVIA (IQV)
(Delayed Data from NYSE)
$251.55 USD
+0.76 (0.30%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $251.48 -0.07 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
IQVIA Holdings (IQV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$273.16 | $312.00 | $220.00 | 8.59% |
Price Target
Based on short-term price targets offered by 19 analysts, the average price target for IQVIA Holdings comes to $273.16. The forecasts range from a low of $220.00 to a high of $312.00. The average price target represents an increase of 8.59% from the last closing price of $251.55.
Analyst Price Targets (19)
Broker Rating
IQVIA Holdings currently has an average brokerage recommendation (ABR) of 1.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 21 brokerage firms. The current ABR compares to an ABR of 1.40 a month ago based on 21 recommendations.
Of the 21 recommendations deriving the current ABR, 16 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 76.19% and 4.76% of all recommendations. A month ago, Strong Buy made up 76.19%, while Buy represented 4.76%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/IQV.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 16 | 16 | 16 | 16 | 16 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.40 | 1.40 | 1.40 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/28/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/31/2024 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
7/24/2024 | Not Identified | Not Identified | Strong Buy | Hold |
7/23/2024 | UBS | Dan Leonard | Strong Buy | Strong Buy |
7/23/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/22/2024 | SVB Securities | Michael Cherny | Strong Buy | Strong Buy |
7/22/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/28/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/6/2024 | Goldman Sachs | Matthew Sykes | Not Available | Strong Buy |
5/3/2024 | Robert W. Baird & Co. | Eric W Coldwell | Hold | Hold |
5/3/2024 | Truist Securities | Jailendra Singh | Strong Buy | Strong Buy |
5/3/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
5/2/2024 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
2/27/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
2/15/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Hold |
12/11/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.40 |
ABR (Last week) | 1.40 |
# of Recs in ABR | 21 |
Average Target Price | $273.16 |
LT Growth Rate | 10.40% |
Industry | Medical - Instruments |
Industry Rank by ABR | 73 of 253 |
Current Quarter EPS Est: | 2.81 |